1 / 27

PAEDIATRIC NON-MEDICINES RESEARCH (PNMR)

PAEDIATRIC NON-MEDICINES RESEARCH (PNMR). Professor Peter Clayton Professor of Child Health and Endocrinology Network Director – GMLC MCRN. WELCOME. To provide a clear picture of PNMR across GM and C&L To discuss what is already in place To look to the future. Who’s who in PNMR

steffi
Download Presentation

PAEDIATRIC NON-MEDICINES RESEARCH (PNMR)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PAEDIATRIC NON-MEDICINES RESEARCH (PNMR) Professor Peter Clayton Professor of Child Health and Endocrinology Network Director – GMLC MCRN Medicines for Children Research Network

  2. WELCOME • To provide a clear picture of PNMR across GM and C&L • To discuss what is already in place • To look to the future Medicines for Children Research Network

  3. Who’s who in PNMR • Discussion Forum – what is happening locally, relationship with MCRN, what support is available • A locally led PNMR study: Triple P • The National Agenda • Discussion Forum – looking to the future Medicines for Children Research Network

  4. Who’s Who • Professor Anne Greenough – Chair of National Specialty Group • Professor Peter Clayton – Member of National Specialty Group for GM and C&L • Sarah Rickard – GMLC Network Manager • 2 GM PNMR Leads: Professor Peter Callery and Dr Clare Murray • 1 C&L PNMR Lead vacancy • 0.6 PNMR Coordinator: Gemma Whiteley Medicines for Children Research Network

  5. PCRN CLRN 34 Local Research Networks 8 Local Research Networks MHRN Co-ordinating Centre MCRN Co-ordinating Centre 25 Local Research Networks NCRN Co-ordinating Centre DRN Co-ordinating Centre 7 Local Research Networks 8 Local Research Networks 8 Local Research Networks DeNDRoN Co-ordinating Centre 8 Local Research Networks SRN Co-ordinating Centre 6 Local Research Networks NIHR CRN Co-ordinating Centre Full population coverage Incomplete population coverage Medicines for Children Research Network Medicines for Children Research Network

  6. Comprehensive Research Networks 25 CLRNs in England 3 in Northwest: Greater Manchester; Cumbria & Lancashire; Cheshire & Merseyside, their role is: To establish and fund an excellent clinical research infrastructure To provide NHS Service Support Costs To provide and deploy resources for research management Medicines for Children Research Network Medicines for Children Research Network

  7. Who’s who in PNMR • Discussion Forum – what is happening locally, relationship with MCRN, what support is available • A locally led PNMR study: Triple P • The National Agenda • Discussion Forum – looking to the future Medicines for Children Research Network

  8. The Portfolio PNMR Only Medicines for Children Research Network

  9. The Portfolio Co-Adopted Medicines for Children Research Network

  10. Recruitment Medicines for Children Research Network

  11. Recent Developments • Appointing 2 PNMR leads in GM, C&L post vacant • Appointing 0.6 WTE PNMR Coordinator • Portfolio has expanded rapidly with new and existing projects identified • Expansion to West Yorkshire • Links have been made with PNMR researchers who have previously been unfamiliar with the Network • Our website now contains PNMR information Medicines for Children Research Network

  12. MCRN vs PNMR Important ‘badge’ for Paediatric Research MCRN is DH priority group and it’s work should not be diluted/distracted by PNMR However, both must work closely and MCRN may be able to provide expertise and infrastructure – economies of scale Medicines for Children Research Network Medicines for Children Research Network

  13. Funding Locally: GMLC receives £535,000 core budget/annum for MCRN GM CLRN provides £188,000/annum for MCRN - now this needs to extend to cover PNMR C&L CLRN provides ~£200,000 for MCRN and now PNMR Medicines for Children Research Network Medicines for Children Research Network

  14. GMLC services Feasibility for sponsors Study proposal development Site identification & selection Feasibility of study at site Approvals Agreements Costings Study set up & initiation Support of study nurse Patient recruitment Data collection & input Training & education Medicines for Children Research Network Medicines for Children Research Network

  15. Who’s who in PNMR • Discussion Forum – what is happening locally, relationship with MCRN, what support is available • A locally led PNMR study: Triple P • The National Agenda • Discussion Forum – looking to the future Medicines for Children Research Network

  16. Who’s who in PNMR • Discussion Forum – what is happening locally, relationship with MCRN, what support is available • A locally led PNMR study: Triple P • The National Agenda • Discussion Forum – looking to the future Medicines for Children Research Network

  17. The National Picture Medicines for Children Research Network

  18. CCRN national specialty groups plus Medicines for Children Research Network Medicines for Children Research Network

  19. PNMR in comparison to the other 25 Specialty Groups Medicines for Children Research Network

  20. Remit of National PNMR Specialty Group To provide the CCRN with access to a national network with topic specific expertise To provide advice on both “do-ability” and more detailed feasibility for both commercial and publicly-funded studies To provide members for adoption committees and provide input into topic specific training Management support provided by MCRN CC MCRN LRNs will coordinate all portfolio studies (with priority given to MCRN studies) Expansion of the existing 12 Clinical Study Groups to incorporate PNMR expertise The CCRN is not funded to drive the portfolio of research in specific topic areas. RCPCH will make available a budget to support the PNMR Specialty Group in those areas which are not funded by the CCRN such as portfolio development and oversight. Medicines for Children Research Network Medicines for Children Research Network

  21. MCRN Clinical Studies Groups • Anaesthesia, Intensive Care, Pain Control and Cardiology • Diabetes, Endocrinology and Metabolic Medicine • Gastroenterology, Hepatology & Nutrition • General Paediatric (including Dermatology) • Methodology • Neonatal • Neurosciences • Pharmacy & Pharmacology • Respiratory & Cystic Fibrosis • RANII (Rheumatology, Allergy, Nephrology,Immunity, and Infection) Medicines for Children Research Network

  22. How do we compare? Medicines for Children Research Network

  23. PNMR recruitment nationally Medicines for Children Research Network

  24. Medicines for Children Research Network

  25. Who’s who in PNMR • Discussion Forum – what is happening locally, relationship with MCRN, what support is available • A locally led PNMR study: Triple P • The National Agenda • Discussion Forum – looking to the future Medicines for Children Research Network

  26. Developing a local PNMR Strategy • Develop effective performance management processes to capture and analyse data on PNMR projects • Raise the profile of PNMR across the region including the benefits of adoption • Improve links with PNMR researchers outside of Manchester • Link PNMR to Medicines research, e.g. • Building cohorts • Long-term pharmacovigilence • Provide a structure & a focus for Paediatric research, and some degree of quality control Medicines for Children Research Network

  27. Greater Manchester, Lancashire & South Cumbria Medicines for Children Research Network 5th Floor, Royal Manchester Children’s Hospital 0161 701 6947 Email: gmlc@mcrn.org.uk www.gmlc-mcrn.org.uk Medicines for Children Research Network

More Related